Breast cancer is the most prevalent cancer among women and predicting pathologic complete response (pCR) after anti-cancer treatment is crucial for patient prognosis and treatment customization. Deep learning has shown promise in medical imaging diagnosis, particularly when utilizing multiple imaging modalities to enhance accuracy. This study presents a model that predicts pCR in breast cancer patients using dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) maps. Radiomics features are established hand-crafted features of the tumor region and thus could be useful in medical image analysis. Our approach extracts features from both DCE MRI and ADC using an encoder with a self-attention mechanism, leveraging radiomics to guide feature extraction from tumor-related regions. Our experimental results demonstrate the superior performance of our model in predicting pCR compared to other baseline methods.
A Polarization and Radiomics Feature Fusion Network for the Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
University College London(伦敦大学学院);Tsinghua University(清华大学);Tsinghua Shenzhen International Graduate School(清华大学深圳国际研究生院);Tsinghua-Berkeley Shenzhen Institute(清华-伯克利深圳学院);Fujian Medical University Cancer Hospital(福建医科大学肿瘤医院);Fujian Cancer Hospital(福建省肿瘤医院)
Convolutional Restricted Boltzmann Machine Based-Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Predictive Enhancement Calibration for Latent Breast MRI Virtual Contrast Enhancement
The First Affiliated Hospital of Chongqing Medical University(重庆医科大学附属第一医院);Chongqing Municipal Health Commission(重庆市卫生健康委员会);Chongqing Translational Medicine Center(重庆市转化医学中心)
Department of Electrical and Computer Engineering, Sungkyunkwan University, Suwon, Korea(延世大学电气与计算机工程系);Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, Korea(延世大学医学院放射科与成像科学中心)
An Interpretable Deep Learning Framework for Discovery and Clinical Validation of Deep Radiomic Signatures in Tumor Classification
Department of Health Outcomes and Biomedical Informatics, University of Florida(健康结果与生物医学信息学系,佛罗里达大学);Tiktok;Department of Biostatistics, MD Anderson Cancer Center(生物统计学系,MD安德森癌症中心);Department of Urology, University of Florida(泌尿科,佛罗里达大学)
RADIFUSION: A multi-radiomics deep learning based breast cancer risk prediction model using sequential mammographic images with image attention and bilateral asymmetry refinement
Monash University Malaysia(莫纳什大学马来西亚分校);The University of Oklahoma(俄克拉荷马大学);Karolinska Institute(卡罗林斯卡学院);Karolinska University Hospital(卡罗林斯卡大学医院);University of Malaya(马来亚大学);The University of Melbourne(墨尔本大学)
TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs
State University of New York at Stony Brook(纽约州立大学石溪分校);Newark Beth Israel Medical Center(纽瓦克贝斯以色列医疗中心);Columbia University Irving Medical Center(哥伦比亚大学欧文医疗中心);Emory University School of Medicine(埃默里大学医学院);Georgia Institute of Technology(佐治亚理工学院)
PD-DWI: Predicting response to neoadjuvant chemotherapy in invasive breast cancer with Physiologically-Decomposed Diffusion-Weighted MRI machine-learning model
Reichman University(赖希曼大学);Technion(以色列理工学院)
乳腺癌新辅助化疗(NAC)后病理完全缓解(pCR)的早期预测在手术计划和优化治疗策略中起着至关重要的作用。最近,提出了基于机器和深度学习的方法,用于从多参数MRI(mp-MRI)数据(包括动态对比增强MRI和弥散加权MRI(DWI))中进行早期pCR预测,并取得了中等成功。我们引入了PD-DWI,这是一种生理分解的DWI机器学习模型,用于从DWI和临床数据预测pCR。我们的模型首先将原始DWI数据分解为影响DWI信号的各种生理线索,然后使用分解的数据以及临床变量作为基于放射学的XGBoost模型的输入特征。我们证明了我们的PD-DWI模型相对于传统机器学习方法的附加价值,用于使用公开可用的乳腺多参数MRI预测NAC反应(BMMR 2)挑战,从mp-MRI数据预测pCR。与挑战测试集排行榜上的当前最佳结果(0.8849 vs. 0.8397)相比,我们的模型大大改善了曲线下面积(AUC)。PD-DWI有可能改善乳腺癌NAC后pCR的预测,减少总体mp-MRI采集时间,并消除造影剂注射的需要。
Breast MRI radiomics and machine learning radiomics-based predictions of response to neoadjuvant chemotherapy -- how are they affected by variations in tumour delineation?
Physically Aware Radiomics Without Interpolation: Disentangling Voxel Geometry and Signal Modification in CT and MRI
Complejo Asistencial Universitario de León(莱昂大学附属医院综合体);Hospital Universitario Rey Juan Carlos(雷·胡安·卡洛斯大学医院);Health Research Institute of the Jiménez Díaz Foundation(希门尼斯·迪亚斯基金会健康研究所);Rey Juan Carlos University(雷·胡安·卡洛斯大学);Universidad de Oviedo(奥维耶多大学);Universidad de León(莱昂大学);IFCA-CSIC(西班牙国家研究委员会高级计算与电子科学研究所);Universidad Autónoma de Chile(智利大学)
Novel Radiomic Measurements of Tumor- Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Case Western Reserve University(凯斯西储大学);Picture Health(Picture Health公司);Stony Brook University(石溪大学);University Hospitals Cleveland Medical Center(克利夫兰大学医院医学中心);Yale School of Medicine(耶鲁医学院);The Cleveland Clinic Foundation (CCF)(克利夫兰诊所基金会(CCF));New York University (NYU) Langone Medical Center(纽约大学(NYU)朗格尼医学中心);Louis Stokes Cleveland Veterans Medical Center(路易斯·斯托克斯克利夫兰退伍军人医学中心)
目的:肿瘤相关血管系统与健康血管的不同之处在于其混乱的结构和扭曲性,这会促进治疗抵抗。这些属性的可测量差异可能有助于根据全身治疗(例如化疗)的可能获益对患者进行分层。在这项工作中,我们提出了一类新的放射性生物标志物,称为定量肿瘤相关血管系统(QuanTAV)特征,并证明了它们预测多种癌症,成像方式和治疗方案的反应和生存的能力。实验设计:我们对558名患者的常规治疗前放射学(CT或对比增强MRI)进行了肿瘤血管分割并计算了扭曲和组织的数学测量值,这些患者接受了乳腺癌(n=371)或非小细胞肺癌(NSCLC,n=187)的四种一线化疗治疗干预策略之一。结果如下:在4种基于化疗的治疗策略中,QuanTAV测量的分类器显著(p<0.05)预测了单独保持测试队列的反应(AUC=0.63-0.71),并且当添加到单独的重要临床变量模型中时,AUC增加了0.06-0.12。QuanTAV风险评分是乳腺癌化疗(p=0.002,HR=1.25,95% CI 1.08-1.44,C指数= 0.66)和NSCLC放化疗(p=0.039,HR=1.28,95% CI 1.01-1.62,C指数=0.66)治疗队列中无复发生存期的预后指标。在所有治疗组中,包括接受化疗的NSCLC患者(p=0.034,HR=2.29,95% CI 1.07-4.94,C指数=0.62),分类QuanTAV风险组具有独立预后。…
To deform or not: treatment-aware longitudinal registration for breast DCE-MRI during neoadjuvant chemotherapy via unsupervised keypoints detection
Radboud University Medical Centre(拉德堡德大学医学中心);The Netherlands Cancer Institute(荷兰癌症研究所);Macao Polytechnic University(澳门理工大学);Maastricht University Medical Centre(马斯特里赫特大学医学中心)
FECT: Classification of Breast Cancer Pathological Images Based on Fusion Features
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School(清华深圳国际研究生院生物制药与健康工程研究所);School of Medicine, Nankai University(南开大学医学院)
A Large Model for Non-invasive and Personalized Management of Breast Cancer from Multiparametric MRI
The Hong Kong University of Science and Technology(香港科技大学);PLA Middle Military Command General Hospital(中国人民解放军中部战区总医院);The University of Hong Kong(香港大学);The Chinese University of Hong Kong(香港中文大学);Yunnan Cancer Hospital(云南省肿瘤医院);th Medical Center of Chinese PLA General Hospital(中国人民解放军总医院第五医学中心);Southern Medical University(南方医科大学)
Response monitoring of breast cancer on DCE-MRI using convolutional neural network-generated seed points and constrained volume growing
Image Sciences Institute, University Medical Center Utrecht(乌得勒支大学医学中心影像科学研究所);Department of Radiology, Antoni van Leeuwenhoek Hospital - The Netherlands Cancer Institute(荷兰癌症研究所安东尼·范·列文虎克医院放射科)
Multi-modal Knowledge Decomposition based Online Distillation for Biomarker Prediction in Breast Cancer Histopathology
School of Biomedical Engineering, Faulty of Medicine, Dalian University of Technology, Dalian, China(生物医学工程学院);Faculty of Information Technology, University of Jyvaskyla, Jyvaskyla, Finland(信息科技学院);School of Software Technology, Dalian University of Technology, Dalian, China(软件技术学院);Department of Radiology, Guangdong Provincial People’s Hospital, Southern Medical University, Guangzhou, China(放射科)
An interpretable automated detection system for FISH-based HER2 oncogene amplification testing in histo-pathological routine images of breast and gastric cancer diagnostics
Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden(德累斯顿工业大学卡尔·古斯塔夫·卡鲁斯大学医院病理研究所);ASGEN GmbH & Co. KG(ASGEN两合有限责任公司);National Center for Tumor Diseases (NCT), Partner Site Dresden(国家肿瘤疾病中心(德累斯顿合作站点));ContextVision AB(康泰视伦公司);Institute for Medical Informatics and Biometry (IMB), Carl Gustav Carus Faculty of Medicine, TU Dresden(德累斯顿工业大学卡尔·古斯塔夫·卡鲁斯医学院医学信息学与生物测量学研究所);Institute of Bioengineering, School of Life Sciences, EPFL(洛桑联邦理工学院生命科学学院生物工程研究所);Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG)(马克斯·普朗克分子细胞生物学与遗传学研究所);Center for Systems Biology Dresden (CSBD)(德累斯顿系统生物学中心)
Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study
Case Western Reserve University(凯斯西储大学);University of Mons(蒙斯大学);Cleveland Clinic(克利夫兰诊所);Yale School of Medicine(耶鲁医学院);Institut Jules Bordet(朱尔斯·博尔代研究所);University Hospitals Cleveland Medical Center(大学医院克利夫兰医学中心);Louis Stokes Cleveland VA Medical Center(路易斯·斯托克斯克利夫兰退伍军人事务医疗中心)
预测对新辅助治疗的反应是乳腺癌中一个令人烦恼的挑战。在这项研究中,我们评估了深度学习从治疗前获得的治疗前动态对比增强(DCE)MRI预测对HER 2靶向新辅助化疗(NAC)的反应的能力。在一项回顾性研究中,包括来自5家机构的157名HER 2+乳腺癌患者的DCE-MRI数据,我们开发并验证了一种深度学习方法,用于预测治疗前对HER 2靶向NAC的病理完全缓解(pCR)。在单一机构接受HER 2靶向新辅助化疗的100名患者用于训练(n=85)和调整(n=15)卷积神经网络(CNN)以预测pCR。确定了利用造影前和造影后DCE-MRI采集的多输入CNN,以实现验证集内的最佳响应预测(AUC=0.93)。然后,使用治疗前DCE-MRI数据在两个独立的测试队列中对该模型进行测试。在第二家机构的28例患者测试集中(AUC=0.85,95% CI 0.67-1.0,p= 0.0008)和包括来自另外3家机构的数据的29例患者多中心试验中(AUC=0.77,95% CI 0.58-0.97,p=0.006),它实现了强大的性能。发现基于深度学习的反应预测模型超过了包含预测临床变量(测试队列中AUC < .65)和半定量DCE-MRI药代动力学测量模型(测试队列中AUC < .60)的多变量模型。这项工作在多个研究中心提出的结果表明,通过进一步验证,深度学习可以提供一种有效可靠的工具来指导乳腺癌的…
Breast Cancer Molecular Subtypes Prediction on Pathological Images with Discriminative Patch Selecting and Multi-Instance Learning
Institute of Computing Technology, Chinese Academy of Sciences(中国科学院计算技术研究所);Xiangya Hospital, Central South University(中南大学湘雅医院);University of Chinese Academy of Sciences(中国科学院大学);Central South University(中南大学)
Quantifying Explainers of Graph Neural Networks in Computational Pathology
IBM Research Zurich(苏黎世IBM研究公司);EPFL Lausanne(洛桑联邦理工学院);ETH Zurich(苏黎世联邦理工学院);Fondazione Pascale(帕斯卡尔基金会);University of Bern(伯尔尼大学);Uppsala University(乌普萨拉大学)
Agent-Based Output Drift Detection for Breast Cancer Response Prediction in a Multisite Clinical Decision Support System
Quibim(Quibim公司);Universitat de Barcelona(巴塞罗那大学);Institució Catalana de Recerca i Estudis Avançats (ICREA)(加泰罗尼亚研究与高等教育学院(ICREA));Computer Vision Center(计算机视觉中心)
Towards a Comprehensive Benchmark for Pathological Lymph Node Metastasis in Breast Cancer Sections
Shenzhen International Graduate School, Tsinghua University(清华大学深圳国际研究生院);National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College(中国医学科学院北京协和医学院肿瘤医院(国家癌症中心/国家临床肿瘤医学中心)深圳医院);Research Institute of Tsinghua, Guangzhou(清华大学广州研究院)
Large Kernel MedNeXt for Breast Tumor Segmentation and Self-Normalizing Network for pCR Classification in Magnetic Resonance Images
Department of Computer Engineering, Kwame Nkrumah University of Science and Technology(计算机工程系,库马西大学科学与技术学院);Infectious Disease Group, Kumasi Centre for Collaborative Research in Tropical Medicine(传染病研究组,库马西热带医学协作研究中心)
PETWB-REP: A Multi-Cancer Whole-Body FDG PET/CT and Radiology Report Dataset for Medical Imaging Research
PET Center, Huashan Hospital, Fudan University(复旦大学附属华山医院PET中心);Shanghai Academy of Artificial Intelligence for Science(上海科学智能研究院);Institute of Science and Technology for Brain-inspired Intelligence, Fudan University(复旦大学类脑智能科学与技术研究院);Shanghai Universal Medical Imaging Diagnostic Center(上海环球医学影像诊断中心);Human Phenome Institute, Fudan University(复旦大学人类表型组研究院);School of Data Science, Fudan University(复旦大学数据科学学院)
Experts' cognition-driven ensemble deep learning for external validation of predicting pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
Sichuan University(四川大学);West China Hospital(华西医院);Zhongjiu Flash Medical Technology Co., Ltd.(中久闪医医疗科技有限公司);Shanxi Provincial Cancer Hospital(山西省肿瘤医院);Sichuan Provincial People’s Hospital(四川省人民医院);The Affiliated Hospital of Southwest Medical University(西南医科大学附属医院)
Deep PCCT: Photon Counting Computed Tomography Deep Learning Applications Review
University of Minho(米尼奥大学);University Medicine Essen(埃森大学医学院);University Hospital RWTH Aachen(亚琛工业大学附属医院);Graz University of Technology(格拉茨技术大学);TU Dortmund University(多特蒙德工业大学)
Graph Representation Learning of Longitudinal Medical Imaging Trajectories for Treatment Response Prediction
Technical University of Munich(慕尼黑工业大学);TUM University Hospital Rechts der Isar(慕尼黑工业大学伊萨尔河右岸大学医院);Helmholtz Munich(慕尼黑亥姆霍兹中心);Universitat de Barcelona(巴塞罗那大学);Medical University of Vienna(维也纳医科大学);King’s College London(伦敦国王学院);Munich Center for Machine Learning(慕尼黑机器学习中心)
Breast Cancer Image Classification Method Based on Deep Transfer Learning
The Hong Kong University of Science and Technology(香港科技大学);University of Southampton(南安普顿大学);Trine University(特莱恩大学);Southwest Jiaotong University(西南交通大学)